-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

641.O1.6 641. Chronic Lymphocytic Leukemias: Basic and Translational: Novel Therapies and Biomarkers Clinically Relevant Abstract

Symposia: Chronic Lymphocytic Leukemias: Basic and Translational Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Lymphoid Leukemias, Biological therapies, Antibody Therapy, apoptosis, adult, Translational Research, CLL, Non-Biological therapies, Lymphomas, elderly, genomics, bioinformatics, B Cell lymphoma, Checkpoint Inhibitor, Diseases, immune mechanism, Immune Disorders, Therapies, Immunotherapy, immunology, aggressive lymphoma, Lymphoid Malignancies, computational biology, young adult , Biological Processes, molecular biology, Technology and Procedures, Study Population, Human, profiling, molecular testing, omics technologies
Monday, December 12, 2022: 10:30 AM-12:00 PM
La Nouvelle Orleans Ballroom AB (Ernest N. Morial Convention Center)
Moderators:
Adrian Wiestner, MD, PhD, NIH, National Heart Lung Blood Institute and Andrew H. Lipsky, MD, Columbia University Medical Center
Disclosures:
Lipsky: AbbVie: Consultancy; AstraZeneca: Consultancy; Synthekine: Consultancy.
10:30 AM

Martí Duran-Ferrer, PhD1,2*, Larry Mansouri3*, Ferran Nadeu, PhD4,5*, Guillem Clot, PhD1,4*, Sujata Bhoi6*, Lesley Ann Sutton7*, Panagiotis Baliakas, MD8*, Sara Ek, PhD, Professor9*, Venera Kuci Emruli10*, Karla Plevova, PhD11*, Zadie Davis12*, Hanna Goransson-Kultima13*, Anders Isaksson14*, Karin E. Smedby, MD, PhD15*, Gianluca Gaidano, MD, PhD16, Anton W. Langerak, PhD17*, Frederic Davi, MD, PhD18*, Davide Rossi, MD, PhD19,20, David Oscier12, Sarka Pospisilova, Prof PhD21*, Maria Karypidou22*, Andreas Agathangelidis, PhD23*, Wolfgang Huber24*, Junyan Lu25*, Thorsten Zenz26, Julio Delgado, MD27, Armando Lopez-Guillermo, MD1,27,28, Paolo Ghia, MD, PhD29, Elías Campo, PhD MD4,30,31,32, Kostas Stamatopoulos, MD, PhD33*, Richard Rosenquist, MD34 and José I. Martín-Subero, PhD1,4,31,35*

1Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
2Centro de Investigación Biomédica en Red de Cáncer, Universitat de Barcelona, Barcelona, Spain
3Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm,, Stockholm, Sweden
4Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
5Molecular Pathology of Lymphoid Neoplasms Group, IDIBAPS, Barcelona, Barcelona, Spain
6Department of Immunology, Genetics and Pathology,, Uppsala University, Uppsala, Sweden
7Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden
8Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Uppsala, Sweden
9Department of Immunotechnology, Lund University, Lund, Sweden
10Lund University, Lund, Sweden
11Central European Institute of Technology, Masaryk University, Brno, Czech Republic
12Royal Bournemouth Hospital, Bournemouth, United Kingdom
13Uppsala University, Uppsala, Sweden
14Uppsala University, Uppsala, SWE
15Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
16Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
17Department of Immunology, Laboratory Medical Immunology, Erasmus MC, Rotterdam, Netherlands
18Department of Biological Haematology, Sorbonne Université, INSERM, Centre de recherche des Cordeliers, AP-HP, Pitié-Salpêtrière Hospital, Paris, FRA
19Division of Hematology,, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
20Institute of Oncology Research, Bellinzona, Switzerland
21Department of Internal Medicine - Hematology and Oncology / Center of Molecular Biology and Gene Therapy, University Hospital Brno and Faculty of Medicine, Brno, Czech Republic
22Centre For Research and Technology Hellas, Thessaloniki, GRC
23Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
24EMBL, Heidelberg, DEU
25European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
26Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, BW, Switzerland
27Servicio de Hematología, Hospital Clínic, IDIBAPS, Barcelona, Spain
28Hematopathology Unit, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Universitat de Barcelona, Barcelona, Spain
29L'Università Vita-Salute San Raffaele Milano and IRCCS Istituto Scientifico San Raffaele, Milano, Italy
30Hematopathology Section, Pathology Department, Hospital Clinic, Barcelona, Spain
31Departament de Fonaments Clínics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain
32IDIBAPS, Barcelona, Spain
33Institute of Applied Biosciences, Centre For Research and Technology Hellas, Thessaloniki, Greece
34Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
35Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

10:45 AM

Shih-Shih Chen, PhD1, Xiao-Jie Yan, MD PhD1*, Luc Van Rompaey, PhD2*, Piotr Zabrocki, PhD2* and Nicholas Chiorazzi, MD1

1Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY
2Argenx BV, Ghent, Belgium

11:00 AM

Laura Llaó Cid, PhD1*, John KL Wong, PhD1*, Marina Wierz, PhD2*, Yashna Paul, PhD1*, Tobias Roider, MD3*, Iria Fernandez Botana2*, Susanne Gonder2*, Alessia Floerchinger1*, Dolors Colomer, PhD4*, Elías Campo, PhD MD5, Sascha Dietrich, M.D.3, Peter Lichter, PhD1*, Marc Zapatka, PhD1*, Etienne Moussay, PhD2*, Jérôme Paggetti, PhD2* and Martina Seiffert, PhD1*

1Molecular Genetics, German Cancer Research Center, Heidelberg, Germany
2Luxembourg Institute of Health, Luxembourg, Luxembourg
3Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
4IDIBAPS-Hospital Clinic, Barcelona, Spain
5Hospital Clinic Provincial, Barcelona, Spain

11:15 AM

Camilla K Lemvigh, MSc1,2*, Erin Michelle Parry, MD, PhD2,3, Stephanie L Deng2*, Nathan J Dangle, MSc2*, Neil Ruthen, BS4*, Binyamin A. Knisbacher, PhD5*, Julien Broséus, MD PhD6,7*, Sébastien Hergalant8*, Romain Guieze, MD, PhD9,10*, Shuqiang Li, PhD2,4,5*, Shanye Yin, PhD2*, Teddy Huang, BS4*, Kenneth J Livak, PhD2,4*, Gad Getz, PhD5,11,12*, Donna S. Neuberg, ScD13, Pierre Feugier, MD, PhD14*, Peter Kharchenko, PhD15*, William G. Wierda, MD, PhD16*, Lars Rønn Olsen, PhD1*, Nitin Jain, MD17 and Catherine J. Wu, MD2,3,5

1Department of Health Technology, Technical University of Denmark, Lyngby, Denmark
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Harvard Medical School, Boston, MA
4Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
5Broad Institute of MIT and Harvard, Cambridge, MA
6Laboratory Department, CHRU Nancy, Vandoeuvre-lès-Nancy, France
7Inserm UMRS1256 Nutrition-Genetique et Exposition aux Risques Environnementaux, University de Lorraine, Nancy, France
8Inserm UMRS1256 Nutrition-Genetique et Exposition aux Risques Environnementaux, University de Lorraine, Nancy, AL, FRA
9EA 7453 (CHELTER), Université Clermont Auvergne, Clermont-Ferrand, France
10Department of Hematology, CHU Clermont Ferrand, Clermont Ferrand, MA, France
11Department of Medicine, Harvard Medical School, Boston, MA
12Department of Pathology, Massachusetts General Hospital Cancer Center, Boston, MA
13Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
14CHRU-Nancy, service d'hématologie biologique, pôle laboratoires, University of Lorraine, Nancy, France
15Department of Biomedical Informatics, Harvard Medical School, Boston, MA
16Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
17Department of Leukemia, MD Anderson Cancer Center, Houston, TX

11:30 AM

Antonella Rigo1*, Tiziana Vaisitti, PhD2, Carlo Laudanna3*, Matilde Micillo2*, Flavia Merigo4*, Alessio Montresor3*, Andrea Sbarbati4*, Kevin Mellert5*, Peter Moeller5, Fabrizio Vinante1*, Silvia Deaglio2* and Isacco Ferrarini, MD PhD1*

1Section of Hematology, Department of Medicine, University of Verona, Verona, Italy
2Department of Medical Sciences, University of Turin, Turin, Italy
3Section of General Pathology, Department of Medicine, University of Verona, Verona, Italy
4Section of Anatomy and Histology, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
5Institute of Pathology, University Hospital of Ulm, Ulm, Germany

11:45 AM

Skye Montoya1*, Jessie Bourcier, MD2*, Meghan C. Thompson, MD3, Mark Noviski, PhD4*, May Tan, BSc4*, Eric Wang, PhD2*, Xiaoli Mi, MD2*, Nivetha Brathaban, MS4*, Carla Barrientos Risso, BSc1,5*, Daniel Tsai, BSc1*, Jordan Ye, BSc4*, Jacob Jahn, BSc1*, Gabriel Pardo, BSc1*, Lee Cabuhat, BSc4*, Ryan Notti, MD, PhD6*, Alejandro Pardo, BSc1*, Maurizio Affer, MS1*, Stephanie Yung, PhD4*, James Luliano, PhD4*, Janine Powers, PhD4*, Daniel W Robbins, PhD4*, Vindhya Nawaratne, PhD1*, Tulasigeri M Totiger, PhD7*, Camila Pena-Velasquez, BS2*, Joanna M. Rhodes, MD, MSCE8, Andrew D. Zelenetz, MD, PhD9, Lindsey Roeker, MD3,9, Hao Lu, PhD4*, Adam Linley, PhD10*, Anthony R. Mato, MD, MSCE3,9, Omar Abdel-Wahab, MD11 and Justin Taylor, MD1

1Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL
2Human Oncology and Pathogenesis Program, Dept. of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Leukemia Service, Dept. of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Nurix Therapeutics, San Francisco, CA
5School of Medicine, Ponce Health Sciences University, Ponce, PR
6Laboratory of Molecular Electron Microscopy, Rockefeller University, New York, NY
7Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami
8Northwell Health Cancer Institute, New Hyde Park, NY
9Memorial Sloan Kettering Cancer Center, New York, NY
10Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
11Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

*signifies non-member of ASH